Trial intelligence / Profile preview

Gemcitabine Combined With 125I Brachytherapy Versus Gemcitabine Alone in Locally Advanced Pancreatic Cancer

NCT00644618Phase 3Completed

Sponsor
Huazhong University of Science and Technology
Start
Jan 2003
Primary completion
Dec 2007
Modality
Small Molecules
01

Overview

A Phase 3 trial of gemcitabine in pancreatic cancer (PC), sponsored by Huazhong University of Science and Technology. Started Jan 2003; status: completed.

02

Drugs

gemcitabine
03

Conditions

pancreatic cancer (PC)

Beyond the preview

Go deeper on NCT00644618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00644618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call